Clinical Trial Update: Role of FCI in the Detection of Proctosigmoiditis Caused by IBD [NA]

View source ↗

Summary

A clinical trial evaluating the role of FCI in detecting proctosigmoiditis in inflammatory bowel disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease
• Proctosigmoiditis

Snippet

Sponsor: NHS Grampian | Conditions: Inflammatory Bowel Diseases, Proctosigmoiditis | NA | Status: WITHDRAWN